DDIAS and myeloid sarcoma: In this sense, in the studies conducted by Muili et al. (30) and Goncalves et al. (28), it was shown that animal models of MS submitted to treatment with PBM exhibit a decrease in oxidative stress markers, such as: nitric oxide (NO), inducible nitric oxide (iNOS) and nitrite.